Cardiology
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF ...
May 22, 2011
0
0
